Skip to main content
TruScreen Group Limited logo

TruScreen Group Limited — Investor Relations & Filings

Ticker · TRU ISIN · NZTRUE0001S7 NZX Manufacturing
Filings indexed 366 across all filing types
Latest filing 2021-06-04 Director's Dealing
Country NZ New Zealand
Listing NZX TRU

About TruScreen Group Limited

https://www.truscreen.com

TruScreen Group Limited develops and manufactures a proprietary cervical cancer screening system that utilizes opto-electrical technology for the real-time detection of precancerous and cancerous tissue. The system employs a single-use sensor to measure tissue response to specific electrical and optical stimuli, processing the data through an integrated algorithm to provide an immediate objective result. By eliminating the requirement for laboratory processing, tissue sampling, and specialized pathology infrastructure, the technology facilitates point-of-care screening in diverse clinical environments. The device is designed to address the limitations of traditional cytology, offering a non-invasive, portable solution that enhances the efficiency of screening programs and improves patient access to diagnostic results.

Recent filings

Filing Released Lang Actions
Director and Officer Disclosure Notice
Director's Dealing Classification · 95% confidence The document is titled 'Disclosure of Directors and Senior Managers Relevant Interests' and references sections of the Financial Markets Conduct Act 2013. It details transactions involving shares by a director or senior manager, including dates, number of shares, and transaction nature. It includes certification by an officer but does not contain financial statements or company performance data. This type of document is a report of personal share transactions by company directors and executives, i.e., insider trades. Therefore, it fits the category 'Director's Dealing' (DIRS). The document length is 4669 characters, which is sufficient to contain detailed transaction information rather than just an announcement. Hence, the classification is DIRS with high confidence.
2021-06-04 English
TRUSCREEN PRELIMINARY RESULTS FOR FY2021
Earnings Release Classification · 95% confidence The document is titled 'Results announcement' and provides summarized financial results for the 12 months ending 31 March 2021, including revenue, net profit/loss, and net tangible assets. It explicitly states that 'Unaudited financial statements accompany this announcement,' indicating that this document itself is a brief announcement of financial results rather than a full detailed report. The document length is only 1632 characters, which is quite short and consistent with an initial earnings release rather than a comprehensive interim or annual report. There is no detailed financial data or analysis present, only key highlights and summary figures. Therefore, this document fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only.
2021-05-31 English
TruScreen Stakeholder Newsletter
Investor Presentation Classification · 85% confidence The document is a detailed newsletter from TruScreen Group Ltd dated May 2021. It includes updates on company activities, market progress, appointments to the board, sales volume growth, clinical evaluations, and strategic initiatives. It contains no formal financial statements or comprehensive financial performance data typical of an Annual Report or Interim Report. It also does not focus on a specific event like a shareholder meeting, voting results, or legal proceedings. The content is more of a management update and operational progress report, but it is not a formal Management Discussion & Analysis (MDA) or Earnings Release (ER) since it lacks detailed financial results or earnings highlights. The document is longer than 5,000 characters and provides substantive operational and strategic information. Given the nature of the content, the best fitting category is Investor Presentation (IP), as it provides detailed information for investors about company strategy, market position, and operational updates, even though it is in newsletter format rather than a formal presentation deck. Confidence is high due to the detailed operational and strategic content aimed at investors and stakeholders.
2021-05-06 English
Research Confirms TruSreeen Suitability in COVID-19 Environ
Regulatory Filings Classification · 95% confidence The document is an NZX announcement dated 24 March 2021, discussing research confirming the suitability of the TruScreen cervical cancer screening device for use in a COVID-19 environment. It contains no financial data, no regulatory filings, no voting results, no management or board changes, no earnings or annual report content. It is a product and research update announcement aimed at investors and the public. The document is about a research confirmation and product suitability, not a financial report or regulatory filing. Therefore, it fits best under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2021-03-23 English
Final Director’s Interest Notice
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options and ordinary shares, and notes the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director. The document length is short and focused solely on director share interests, matching the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades).
2021-03-03 English
Director and Officer Disclosure Notice
Director's Dealing Classification · 95% confidence The document is titled 'Initial Disclosure Notice' and concerns the disclosure of directors and senior managers' relevant interests under the Financial Markets Conduct Act 2013. It details the name of the director, the date of disclosure, the nature of the relevant interest, and includes a certification statement by an officer. There are no financial statements, management discussion, or report content. The document is a regulatory disclosure of insider shareholdings or interests by directors, which fits the definition of Director's Dealing (DIRS). The document length is short and focused solely on insider interest disclosure, not a full report or announcement of a report publication. Therefore, the correct classification is DIRS with high confidence.
2021-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.